Nutex Health面临集体诉讼,指控证券欺诈,涉及误导性财务报表和股票价格暴涨。 Nutex Health faces a class action lawsuit over alleged securities fraud involving misleading financial statements and inflated stock prices.

Nutex Health Inc. (NUTX)正面临针对证券欺诈指控的集体诉讼,2024年8月8日至2025年8月14日期间购买股票的投资者可能有资格收回损失。 Nutex Health Inc. (NUTX) is facing a class action lawsuit over allegations of securities fraud, with investors who bought shares between August 8, 2024, and August 14, 2025, potentially eligible to recover losses. 诉讼要求该公司就其财务健康作出虚假或误导性陈述,包括谎报其与第三方供应商HaloMD的关系所得收入,据称后者从事欺诈性保险仲裁做法。 The lawsuit claims the company made false or misleading statements about its financial health, including misrepresenting revenue from its relationship with third-party vendor HaloMD, which allegedly engaged in fraudulent insurance arbitration practices. 它还指控Nutex公司不适当地将库存补偿归类为股本,夸大了在消除内部控制缺陷方面取得的进展,并增加了SEC申报延迟的风险。 It also alleges Nutex improperly classified stock-based compensation as equity, overstated progress in fixing internal control weaknesses, and increased the risk of delayed SEC filings. 据称这些行动夸大了公司的财务前景和股票价格。 These actions allegedly inflated the company’s financial prospects and stock price. 主要原告的最后期限是2025年10月21日,投资者可通过律师事务所寻求追偿,而无需预付费用。 A lead plaintiff deadline is set for October 21, 2025, and investors may seek recovery through law firms handling the case with no upfront costs.